Comparative outcomes of aflibercept biosimilars and reference aflibercept in nAMD: a systematic review and meta-analysis.

BMJ Open Ophthalmol · 2025 · PMC12581046 · PMID 41177553

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The pooled RR using a random-effects model was 1.19 (95% CI 0.98 to 1.45, p=0.079), favouring the biosimilar group; however, this result did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.